NCT07066150View on ClinicalTrials.gov

A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 6, 2025

Primary Completion Date

March 6, 2025

Study Completion Date

April 2, 2025

Conditions
Atopic Dermatitis (AD)PsoriasisAcne VulgarisContact DermatitisPhotodamaged SkinIchthyosisXerosis Cutis
Interventions
OTHER

Apply a cream containing 0.05% marula oil-derived ceramide NPs

The participants were requested to apply a cream containing 0.05% marula oil-derived ceramide NPs on their faces twice daily for 28 consecutive days.

Trial Locations (1)

266101

SGS-CSTC Standards Technical Services (Qingdao) Co., Ltd., Qingdao

All Listed Sponsors
collaborator

SGS S.A.

INDUSTRY

lead

Shanghai Chicmax Cosmetic Co., Ltd.

INDUSTRY

NCT07066150 - A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement | Biotech Hunter | Biotech Hunter